نتایج جستجو برای: eortc

تعداد نتایج: 2556  

2015
Μaria Arvaniti Νikolaos Danias Εleni Theodosopoulou Vassilis Smyrniotis Μ. Karaoglou Pavlos Sarafis

INTRODUCTION The treatment of pancreatic cancer is a complex problem, due to late diagnosis, the need for specialized surgical treatment, the large number of relapses and poor survival. OBJECTIVE To evaluate the quality of life of patients with periampulary pancreatic cancer before and after pancreatoduodenectomy (PD). MATERIAL & METHOD The sample was collected in the "Attikon" University G...

Journal: :Sarcoma 2001
John Gibbs

s—Invited Speakers The past 25 years of EORTC soft tissue and bone sarcoma group A. VAN OOSTEROM (Department of Oncology, U.Z. Gasthuisberg, KU Leuven, Leuven) Preliminary meetings in April—to June 1976—between founding members led to the full development of a protocol in which CyVADic was compared with CyV-Adic in advanced soft tissue sarcoma. This protocol was approved by the EORTC Protocol R...

2017
Jaiprakash Aggarwal Santam Chakraborty Sarbani Ghosh Laskar Vijay M Patil Kumar Prabhash Atanu Bhattacharya Vanita Noronha Nilendu C Purandare Amit Joshi Naveen Mummudi Jitendra Arora Rupali Badhe

INTRODUCTION Reference data for European Organization for Research and Treatment of Cancer (EORTC) quality of life questionnaires do not include studies from the Indian subcontinent. The objective of the current study was to establish a reference dataset for Indian patients of non-small cell lung cancer (NSCLC) presenting with brain metastases (BM). MATERIAL AND METHODS One hundred forty pati...

Journal: :Thorax 2000
J G Edwards K R Abrams J N Leverment T J Spyt D A Waller K J O'Byrne

BACKGROUND The incidence of malignant mesothelioma is increasing. There is the perception that survival is worse in the UK than in other countries. However, it is important to compare survival in different series based on accurate prognostic data. The European Organisation for Research and Treatment of Cancer (EORTC) and the Cancer and Leukaemia Group B (CALGB) have recently published prognosti...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2010
Stuart A Grossman Xiaobu Ye Steven Piantadosi Serena Desideri Louis B Nabors Myrna Rosenfeld Joy Fisher

PURPOSE Novel agents are currently combined with radiation and temozolomide (RT + TMZ) in newly diagnosed glioblastoma using overall survival as the primary end point. Results of these phase II studies are typically compared with the phase III European Organization for Research and Treatment of Cancer (EORTC) survival data that resulted in RT + TMZ becoming standard therapy. EXPERIMENTAL DESI...

2011
Sultan S. Alkhateeb Mischel Neill Sas Bar-Moshe Bas Van Rhijn David M. Kakiashvili Neil Fleshner Michael Jewett Michel Petein Claude Schulman Sally Hanna Peter J. Bostrom Thierry Roumeguere Shahrokh F. Shariat Sandrine Rorive Alexandre R. Zlotta

BACKGROUND AND OBJECTIVES To evaluate the long-term prognostic value of the combination of the EORTC risk calculator and proapoptotic, antiapoptotic, proliferation, and invasiveness molecular markers in predicting the outcome of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) treated with intravesical Bacille Calmette-Guérin (BCG) therapy. MATERIALS AND METHODS This stu...

Journal: :European journal of endocrinology 2013
A Ríos J M Rodríguez B Ferri E Matínez-Barba B Febrero P Parrilla

PURPOSE Most prognostic systems for differentiated carcinoma have been designed for papillary carcinoma. OBJECTIVE To analyze the value of the existing prognostic systems for evaluating follicular carcinoma and to determine whether any of them have a better predictive effect. METHODS A total of 66 follicular carcinomas were analyzed. The following prognostic systems were studied: EORTC, AGE...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2000
R Willemze C J Meijer

Primary cutaneous lymphomas differ significantly from their nodal equivalents in clinical behaviour and prognosis, and often require a different therapeutic approach. Since currently used classification systems for non-Hodgkin lymphomas do not or insufficiently recognize the special character of these lymphomas, primary cutaneous lymphomas are not uncommonly diagnosed incorrectly, and/or treate...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید